Acceleron Pharma Inc. (XLRN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acceleron Pharma Inc. ("Acceleron" or the "Company") (NASDAQ: XLRN). The investigation concerns whether Acceleron and its board of directors have breached fiduciary duties.
If you are aware of any facts relating to this investigation, or purchased Acceleron shares, you can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.